Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06444425Enrolling By Invitation

Artificial Intelligence in Detecting Cardiac Function

Role: collaborator

NCT04915001Completed

An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province

Role: collaborator

NCT04915690Unknown

Investigation on the Practice Status of Emergency Stuff

Role: collaborator

NCT04934878Completed

Regional Treatment Flow and Prognosis ofTraumatic Thoracic Aortic Injuries：A Multi-center Retrospective Analysis in Zhejiang Province During 11 Years

Role: collaborator

NCT04234321Not ApplicableUnknown

Clinical Study of Kangfuxin and Basic Fibroblast Growth Factor in Promoting the Healing of Donor Site

Role: collaborator

All 5 trials loaded